LXRepair off to a roaring start

LXRepair, an expert in enzyme activity testing and DNA repair, was created on September 26 from a research project at INAC. It was founded by an INAC researcher and a business developer who both have ambitious growth plans: they expect to make their first kits by the end of this year and start hiring staff early next. By the end of 2014 they plan to have completed a successful capital-raising round and have expanded to six employees.
The start-up targets two markets: pharmaceutical research, with systems for characterizing molecules that can interfere with DNA repair; and clinical research, with methods for identifying patients responsive to chemotherapy or highly sensitive to radiation therapy. The latter market should quickly become the company’s main growth driver

Contact: sylvie.sauvaigo@cea.fr

Facebook

Twitter